Escolar Documentos
Profissional Documentos
Cultura Documentos
Annual Meeting
and Exposition
December 9-12 Atlanta, Georgia
O
Kenneth C. Anderson, MD, President
Scott A. Armstrong, MD, PhD Joseph R. Mikhael, MD
n behalf of the American Society of Hematology 2017 Scientific Program Co-Chair Chair, Committee on Communications Alexis Thompson, MD, MPH, President-Elect
(ASH), I am pleased and honored to invite you to the Belinda R. Avalos, MD Charles Mullighan, MBBS (Hons), MD Roy L. Silverstein, MD, Vice President
Chair, Committee on Promoting Diversity Chair, Committee on Scientific Affairs Robert A. Brodsky, MD, Secretary
59th ASH Annual Meeting and Exposition, the premier
Nancy Berliner, MD Robert Negrin, MD Susan B. Shurin, MD, Treasurer
event in malignant and non-malignant hematology. This Deputy Editor, Blood Editor-in-Chief, Blood Advances COUNCILLORS
years meeting will take place in the vibrant city of Atlanta, Robert A. Brodsky, MD Laurie Sehn, MD Steven L. Allen, MD
Georgia, and will continue to provide an exceptional Secretary and Abstract Review Coordinator 2017 Education Program Co-Chair
John C. Byrd, MD
Theresa L. Coetzer, PhD Mikkael A. Sekeres, MD
educational experience and welcoming space for trainees, Chair, International Members Committee Editor-in-Chief, ASH Clinical News;
Mary C. Dinauer, MD, PhD
Cynthia E. Dunbar, MD
physicians, scientists, educators, and industry professionals John Crispino, PhD
2018 Education Program Co-Chair
Terry Gernsheimer, MD
in hematology from around the globe. 2018 Scientific Program Co-Chair Roy L. Silverstein, MD
Michelle M. Le Beau, PhD
Vice President
Mark A. Crowther, MD
Martin S. Tallman, MD
Chair, Committee on Quality; Martha Sola-Visner, MD
We have an exciting program planned, which includes 2018 Education Program Co-Chair 2018 Scientific Program Co-Chair Jane N. Winter, MD
the highest-caliber science and invaluable information on Adam Cuker, MD Martin S. Tallman, MD
2017 Education Program Co-Chair Executive Editor, Hematology 2017
the most important areas of clinical progress. In the era of
Jason Gotlib, MD Alexis Thompson, MD, MPH
precision medicine, I am particularly excited to highlight Editor-in-Chief, The Hematologist President-Elect
Kenneth C. Anderson, MD the high-impact and cross-cutting areas of genomics and Michael L. Linenberger, MD Andrew S. Weyrich, PhD
President Chair, Committee on Educational Affairs 2017 Scientific Program Co-Chair
immunology, which are making it possible to take these
revolutionary treatments from the bench to the bedside,
directly benefiting the patients we serve. These topics and
others will be explored throughout the meeting in a forum
that fosters scientific exchange and collaboration.
#ASH17 49
Connect with 59th ASH Annual
Table of Contents
Meeting Overview ............................................................ 2
Schedule-at-a-Glance ........................................................ 4
Annual Meeting
and Exposition Exposition ........................................................................ 41
December 9-12 Atlanta, Georgia
NEW
THIS
YEAR
The ASH annual meeting is the premier event in malignant and non-malignant hematology, celebrating
the latest research and clinical advances in the field. The 59th ASH Annual Meeting will provide countless
opportunities for participants to advance their research, improve their practice, and connect with colleagues.
Key Dates
Abstract Submission Website Available June 1 August 2, 11:59 p.m. Pacific Time
ASH Foundation Run/Walk Registration Opens July 6, 11:00 a.m. Eastern Time
Early-Bird Registration and Housing Opens for ASH Members Only July 19, 11:00 a.m. Eastern Time
Advance Registration Opens for ASH Members and Non-Members August 9, 11:00 a.m. Eastern Time
Call for Late-Breaking Abstract Submissions October 20 30, 11:59 p.m. Pacific Time
Meeting Registration Cancellation Deadline November 21, 11:59 p.m. Eastern Time
Free Resources
Attendees may learn more about the
meeting by taking advantage of the follow-
ing resources included with full meeting
registration:
On-site Program Book
Hematology 2017, the ASH Education
Program
ASH News TV, a daily newscast
ASH News Daily, the daily on-site
newspaper
Pre-order during the annual meeting registration process or on site, and receive up to a $100
discount as well as access to select sessions as early as 24 hours after the live session.
*Please note that webcast packages do not include the oral abstract sessions.
#ASH17 3
Schedule-at-a-Glance
The following schedule is preliminary and subject to change. For the most up-to-date meeting information,
download the annual meeting app or visit www.hematology.org/annual-meeting.
7:30 a.m. 9:00 a.m. Simultaneous Oral Sessions 9:00 a.m. 10:00 a.m. E. Donnall Thomas Lecture and Prize
9:00 a.m. 8:00 p.m. Poster Viewing 10:00 a.m. 10:30 a.m. Coffee Break (Exhibit Hall)
NEW
9:00 a.m. 8:00 p.m. Global Capacity-Building Showcase THIS
YEAR
10:00 a.m. 2:00 p.m. Exhibits Open
9:00 a.m. 9:30 a.m. Coffee Break (Poster Hall) 10:00 a.m. 8:00 p.m. Poster Viewing
NEW
9:30 a.m. 11:00 a.m. Education/Scientific Program 10:00 a.m. 8:00 p.m. Global Capacity-Building Showcase THIS
YEAR
9:30 a.m. 11:00 a.m. Simultaneous Oral Sessions 10:30 a.m. 12:00 noon Education Program
9:30 a.m. 11:00 a.m. Special Scientific Symposium 10:30 a.m. 12:00 noon Simultaneous Oral Sessions
10:00 a.m. 5:00 p.m. Exhibits Open 10:30 a.m. 12:00 noon Spotlight Sessions
11:00 a.m. 12:30 p.m. Complimentary Light Lunch Available in 12:00 noon 1:30 p.m. Complimentary Light Lunch Available in
Exhibit Hall Exhibit Hall
11:15 a.m. 12:15 p.m. Continuing Conversations With the 12:15 p.m. 1:15 p.m. ASH Choosing Wisely Campaign:
Speakers 2017 ASH Choosing Wisely Champions
11:15 a.m. 12:15 p.m. Featured Topic Discussion 12:15 p.m. 1:15 p.m. Featured Topic Discussion
11:15 a.m. 12:15 p.m. How I Treat: Bringing Science to Clinical 12:15 p.m. 1:15 p.m. Meet the Blood Editors
Dilemmas SESSION
TICKETED
#ASH17 5
Program Guide
General Sessions
These signature sessions are designed to be of interest to a broad and diverse audience. They include the
prestigious Plenary Scientific Session, Best of ASH, the Presidential Symposium, and special lectures and awards
honoring distinguished leaders in the field.
* Atlanta was named one of the New York Times top places to visit
since ASH last held its annual meeting in the city. Around every
corner is a new attraction, restaurant, or shopping opportunity.
#ASH17 7
Program Guide
General Sessions
#ASH17 9
Program Guide
General Sessions
* tlanta welcomes
A
more than 1 million
international
visitors each
year. From arts
and culture to
music and cuisine,
the city is full
of multicultural
opportunities for
everyone.
CHAI R:
Kenneth C. Anderson, MD, President,
American Society of Hematology, Dana-
Farber Cancer Institute, Boston, MA
S PEAK E R S:
Richard A. Young, PhD, Whitehead Institute
for Biomedical Research, Cambridge, MA
Chromosome Structure and Function in
Health and Disease
Margaret A. Goodell, PhD, Baylor College of
Medicine, Houston, TX
Epigenetic Regulation in Normal and
Malignant Hematopoiesis
James Bradner, MD, Novartis, Cambridge, MA
Therapeutic Targeting of Chromatin
#ASH17 11
Program Guide
Special-Interest Sessions
These smaller sessions provide the opportunity for ASHs various communities to focus on specific
topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in
hematology, to the impact of ASHs international outreach programs.
#ASH17 13
Program Guide
Special-Interest Sessions
A December 2015 study from the Mayo ASH Member Without Annual $200
Clinic reported that physician burnout is on Meeting Registration
the rise; across all medical specialties, the
physician burnout rate rose from 45 percent Non-Member With Annual $200
in 2011 to 54 percent in 2014. In 2015, Meeting Registration
ASH Clinical News reported in Beating
Burnout: When Clinicians Are Overworked, Non-Member Without Annual $275
Overtired, and Overwhelmed that the most Meeting Registration
common complaints among todays practic-
ing hematologists are delayed, inadequate, *The registration fee includes continental
and reduced reimbursement, high staff breakfast and a coffee break.
turnover, poor recruitment and retention,
and understaffing all causes of burnout.
Reports indicate that the advent of elec-
tronic health records and federal reporting Atlanta Fun Fact
mandates have added to physician burnout
and that the implementation of the Medicare
Access and CHIP Reauthorization Act
(MACRA) has the potential to create addi-
tional burden, especially for small practices
lacking in administrative resources. Speakers
will address the problem of physician burn-
out and focus on sustainability, proposing
coping methods and potential solutions.
Training Program
Directors Workshop
Friday, December 8
1:00 p.m. 5:00 p.m.
CHAI R:
Ann S. LaCasce, MD, Dana-Farber Cancer
Institute, Boston, MA
S PEAK E R S:
Christian Cable, MD, Baylor Scott & White
Health, Round Rock, TX
ACGME Update 2017
Alice J. Cohen, MD, Newark Beth Israel
Medical Center, Newark, NJ
Hematology Course For U.S. Participants
Gerald A. Soff, MD, Memorial Sloan Kettering Directors Workshop
Cancer Center, New York, NY
Having The Talk With Fellows Sunday, December 10
7:00 a.m. 9:00 a.m. ASH Grassroots Network
Alfred Lee, MD, PhD, Yale University School
of Medicine, New Haven, CT
Lunch
Michael J. Borowitz, MD, PhD, Johns Hopkins CHAI R:
Saturday, December 9
University, Baltimore, MD Leslie Renee Ellis, MD, Wake Forest School of
Its in Our Blood
11:15 a.m. 12:15 p.m.
Medicine, Winston-Salem, NC
The Training Program Directors Workshop S PEAK E R S: Thanks to ASHs advocacy efforts and
provides an interactive forum for directors of the ASH Grassroots Network, issues
all hematology-related training programs to Jennifer C. Kesselheim, MD, MEd, Dana-Farber important to the future of hematology have
learn from educators, regulators, and each Cancer Institute, Boston, MA been brought to the attention of the U.S.
other. This years session will feature a new Knowles Adult Learning Theory Congress and federal agencies. The ASH
format. Three topics will be covered, and Rajiv K. Pruthi, MBBS, Mayo Clinic, Rochester, Grassroots Network Lunch provides a
two of them will have table-top exercises to MN forum for interested members to learn how
engage participants. The Flipped Classroom: Pros they can participate in ASHs advocacy
efforts, communicate with Congress and the
Dr. Christian Cable will return for an update Neil Lachant, MD, MD Anderson Cancer White House, become effective advocates
from the Accreditation Council for Graduate Center at Cooper, Camden, NJ for hematology, and discuss the Societys
Medical Education (ACGME). Dr. Cable is The Flipped Classroom: Cons legislative and regulatory priorities, including
the current chair of the ACGMEs Residency funding for the National Institutes of Health
Review Committee for Internal Medicine Amy K. OSullivan, PhD, Innovus Pharma,
(NIH). An overview of the Societys 2017
and a former hematology/oncology training Medford, MA
advocacy accomplishments and a preview
program director. An Overview of Qualitative Research
of the Societys 2018 advocacy agenda will
Methodology
Drs. Alice Cohen and Gerald Soff will also be provided.
discuss how to have an effective career Ariela L. Marshall, MD, Mayo Clinic, Rochester,
Please note that this session will mainly
development talk with fellows, with a focus MN
focus on ASHs advocacy efforts related to
on counseling fellows for careers in hema- ASH Medical Educators Institute Spotlight
NIH funding and research; those interested
tology. Topics to be covered will include in the Societys practice-related advocacy
whether to double board and lab-based The Hematology Course Directors Workshop
will continue to offer practical tips and a efforts are encouraged to attend the ASH
science versus clinical research. Practice Partnership Lunch on Sunday,
place of camaraderie for those involved with
Drs. Alfred Lee and Michael Borowitz will teaching hematology to medical students. December 10.
share innovative tools they have employed in The workshop will focus on pedagogy, new
hematology training. The session will provide techniques, scholarship on a yearly basis, and
a chance to refocus on the basics of a a highlight of one participants project from
hematology fellowship: teaching hematology the 2016 ASH Medical Educators Institute.
to fellows. Topics to be covered include Knowles adult
learning theory, a pro and con discussion on
the flipped classroom, and an examination of
qualitative research methodology.
#ASH17 15
Program Guide
Special-Interest Sessions
This event will showcase training and Amy E. Herman, JD, MA, Author, Visual
S PEAK E R S:
research opportunities geared toward Intelligence, New York, NY
increasing the diversity of scholars in Elaine Schattner, MD, Forbes Contributor;
the field of hematology. The highlight of Weill Cornell Medical College, New York, NY Scientifically and clinically, the study
the session will be scientific presenta- of blood commands a professional
Mohamad Mohty, MD, PhD, Saint-Antoine engagement that can lead hematologists
tions fromASH Minority Medical Student Hospital, Paris, France
Award and Minority Resident Hematology to lose sight of the complex notions held
Award Program participants. The recep- John P. Leonard, MD, NewYork-Presbyterian/ by the non-medical world. This session will
tion will also feature poster presentations Weill Cornell Medical Center, New York, NY showcase art historian Amy E. Herman,
by students participating in two Minority whose work shines a unique light on the
Research Supplement programs from the Panelists will discuss their personal best intersection of medicine and humanity.
National Institutes of Health (NIH) as well as practices for starting and maintaining quality In her celebrated seminar, The Art of
an announcement about the ASH-AMFDP conversations relevant to hematology on Perception, Ms. Herman has trained experts
Award, a partnership between ASH and the Twitter and other social media platforms. from many fields how to perceive and
Harold Amos Medical Faculty Development Topics to be addressed include using social communicate better. By showing people
Program of the Robert Wood Johnson media for collaboration and crowdsourcing how to look closely at images, she helps
Foundation. Representatives from the NIH as well as tips for more efficient use of social them hone their visual intelligence, a set of
will be available to provide information about media. skills all individuals possess but that few
their training and research offerings. know how to use effectively. Ms. Herman
has spent more than a decade teaching
*
communication. drive efforts to deliver health care to some
of the worlds most disadvantaged popula- One of the largest Hindu
tions. Attendees will also learn how they can Temples outside of India
make an impact on hematology care in other is located in the Atlanta
regions through ASHs international outreach
Networking Reception for programs.
metro area.
Female Hematologists
Monday, December 11
7:30 p.m. 9:00 p.m.
CO-CHAI R S:
Linda J. Burns, MD, National Marrow Donor
Program/Be the Match, Minneapolis, MN
Christine Chomienne, MD, PhD, INSERM
Hpital Saint-Louis, Paris, France
#ASH17 17
Program Guide
Trainee Activities and Services
Navneet S. Majhail, MD, Cleveland Clinic, Dr. Neil Shah will cover how to find, engage,
Trainee Day Cleveland, OH and define roles of research collaborators
Statistical Considerations in Health Outcomes as well as how to value all members of the
Friday, December 8 and Clinical Effectiveness Research team. It will also address how to find collabo-
12:00 noon 5:00 p.m. rators who understand both the science and
Mikkael A. Sekeres, MD, Cleveland Clinic, clinical aspects of a research program and
Cleveland, OH how to effectively partner with those who do
CHAI R: Statistical Considerations in Phase II and III not see both sides.
Clinical Trials
Alison W. Loren, MD, University of
Pennsylvania, Philadelphia, PA Rosemarie Mick will cover how to collabo- Didactic Session: Non-Traditional
rate with a statistician to create effective Career Development
This half-day workshop is intended to statistical models for basic, translational, and
support and encourage trainees in the field 4:00 p.m. 5:00 p.m.
phase I trials. It will also address sample size,
of academic hematology and enhance their power calculations, confounding variables,
career development. The program will be and bias. S PEAK E R S:
presented through didactic and interactive
Dr. Navneet Majhail will cover how to write a Benjamin Kim, MD, Genentech, Los Angeles,
small-group breakout sessions, which will
clearly defined research question and how CA
allow ample time for discussion. Important
information on trial design, how to build a to select appropriate statistical models for Danielle M. Townsley, MD, National Heart,
research team, and non-traditional career health outcomes and clinical research. Lung, and Blood Institute, National Institutes
development opportunities in hematology will of Health, Bethesda, MD
Dr. Mikkael Sekeres will cover how to
be presented.
collaborate with a statistician to create Ann Farrell, MD, U.S. Food and Drug
A boxed lunch will be provided. Space is effective statistical models for phase II and III Administration, Silver Spring, MD
available on a first-come, first-served basis. clinical trials.
As seating is limited, attendees are strongly This session will highlight careers in hematol-
encouraged to arrive early. No additional Breakout Sessions ogy outside the usual realms of academic
participants will be allowed in the rooms medicine and clinical practice. There will
once these sessions are filled. 2:45 p.m. 3:45 p.m. be speakers from the U.S. Food and Drug
Administration, the National Institutes of
Didactic Session: Statistics and S PEAK E R S: Health, and industry. Each speaker will
Trial Design address the pros and cons of his/her particu-
David P. Steensma, MD, Dana-Farber lar career path, followed by an interactive
12:00 noon 1:15 p.m. Cancer Institute, Boston, MA discussion and Q&A.
Research Teams in Clinical Trials
S PEAK E R: Linda J. Burns, MD, National Marrow
Sara K. Vesely, PhD, University of Oklahoma Donor Program/Be the Match,
Health Sciences Center, Oklahoma City, OK Minneapolis, MN Trainee Welcome
How to Build a Research Team: Research
This session will discuss the importance of Teams in Health Outcomes and Clinical
Reception
an effective trial design as well as how best Effectiveness Research
to partner with a statistician to make sure Friday, December 8
your study is appropriate, achievable, and Neil P. Shah, University of California 5:00 p.m. 7:00 p.m.
meaningful. San Francisco, San Francisco, CA
Research Teams in Translational Studies This informal social event provides the
Breakout Sessions opportunity for undergraduates, medical and
Dr. David Steensma will cover how to devel- graduate students, residents, and fellows
1:30 p.m. 2:30 p.m. op a team to engage in clinical research, (MD and PhD) to gather with their peers.
including how to position yourself as a junior The reception will include an overview of
S PEAK E R S: researcher to ultimately design and lead ASH trainee resources, a guide to the annual
clinical trials. meeting for trainees, and brief remarks from
Rosemarie Mick, MS, University of the ASH president.
Pennsylvania, Philadelphia, PA Dr. Linda Burns will cover the important roles
Statistical Considerations for Basic, within health outcomes and clinical effective-
Translational, and Phase I Trials ness research as well as how to participate
in and eventually lead a research team.
Lunch Sessions Clinical Burton F. Alexander III, MD, Virginia Kenneth Adler, MD, Regional Cancer
Careers in Oncology Associates, Norfolk, VA Care Associates, Morristown, NJ
Saturday, December 9 Hematology
Harriet Bering, Harvard Vanguard David C. Portnoy, MD, West Clinic,
11:15 a.m. 12:15 p.m. Medical Associates, Beverly, MA Memphis, TN
CHAI R: Clinical Hetty E. Carraway, MD, Cleveland Joseph H. Antin, MD, Dana-Farber
Malignant Clinic, Cleveland, OH Cancer Institute, Harvard Medical
Jennifer C. Kesselheim, MD, Dana- Hematology/ School, Boston, MA
Farber Cancer Institute, Boston, MA Gabriel Mannis, University of
Blood and
California San Francisco, San Elihu H. Estey, MD, University of
Marrow
These roundtable discussions will Francisco, CA Washington, Seattle, WA
Transplant
provide an intimate venue for trainees
to meet with leaders in hematology Clinical Non- Anita Rajasekhar, MD, University Andrew D. Leavitt, MD, University
to discuss specific career develop- Malignant of Florida Shands Hospital, of California San Francisco, San
ment topics. There will be two rooms Hematology Gainesville, FL Francisco, CA
reserved for these sessions, with two
Ted Wun, MD, University of Cindy A. Leissinger, MD, Tulane
tables per room for each career area California Davis School of Medicine, University School of Medicine,
and one faculty member at each table Sacramento, CA New Orleans, LA
leading the discussion. Each table will
hold approximately six to 10 people. Government Albert Deisseroth, MD, PhD, U.S. Craig Hooper, PhD, Centers for
A boxed lunch will be provided. Space Food and Drug Administration, Silver Disease Control and Prevention,
is available on a first-come, first-served Spring, MD Atlanta, GA
basis. As seating is limited, attendees Elaine S. Jaffe, MD, National Cancer Keith Hoots, MD, National Heart,
are strongly encouraged to arrive Institute, National Institutes of Health, Lung, and Blood Institute, National
early. No additional participants will Bethesda, MD Institutes of Health, Bethesda, MD
be allowed in the rooms once these
sessions are filled. Industry James Bradner, MD, Novartis, Sophia Khaldoyanidi, Spectrum
Boston, MA Pharmaceuticals, Inc., Weston, MA
Patrick F. Fogarty, Pfizer Inc., Stephen J. Simko, MD, Genentech,
Collegeville, PA San Francisco, CA
Laboratory Neil Shah, MD, PhD, University of Janis L. Abkowitz, MD, University of
and California San Francisco, San Washington, Seattle, WA
Translational Francisco, CA
Karin E. Finberg, MD, PhD, Pathology,
Hematology
Michelle Sholzberg, MDCM, St. Yale School of Medicine, New Haven,
Michaels Hospital, Toronto, Canada CT
Medical Karen Hook, MD, University Kristie Blum, MD, Emory University
Educators of Connecticut Health Center, Medical Center, Atlanta, GA
Farmington, CT
Elaine Muchmore, MD, University of
Martina Trinkaus, MD, St. Michaels California San Diego, San Diego, CA
Hospital, Toronto, Canada
Pediatric Anthony Chan, MBBS, McMaster Neil Goldenberg, MD, PhD, Johns
Hematology/ University, Hamilton, Canada Hopkins All Childrens Hospital, St.
Oncology Petersburg, FL
Cindy Neunert, MD, Columbia
University Medical School, New York, Naomi Winick, MD, University of
NY Texas Southwestern Medical Center,
Dallas, TX
Transfusion Richard Kaufman, MD, Brigham and Lawrence Goodnough, MD, Stanford
Medicine Womens Hospital, Boston, MA University, Stanford, CA
Gary Schiller, MD, David Geffen Cassandra Josephson, MD, Emory
School of Medicine at UCLA, Los University School of Medicine,
Angeles, CA Atlanta, GA
#ASH17 19
Program Guide
Trainee Activities and Services
The Education Program will be held from Saturday, December 9, through Monday, December 11, with
each session being offered twice. A question-and-answer period will occur at the end of each individual speaker
presentation. Chapters based on these sessions will be published in Hematology 2017, the ASH Education Program.
E D U C AT I O N P R O G R A M C O - C H A I R S
The Challenge of Primary
Adam Cuker, MD Laurie Sehn, MD and Secondary Central
University of Pennsylvania, British Columbia Cancer
Philadelphia, PA Agency, Vancouver, Nervous System (CNS)
Canada Lymphoma
CHAI R:
James L. Rubenstein, MD, PhD, University of
California San Francisco, San Francisco, CA
S PEAK E R S:
Malignant Acute Myeloid Leukemia Andres J.M. Ferreri, MD, IRCCS San Raffaele
Scientific Institute, Milan, Italy
Hematology (AML): How Can We Therapy of Primary CNS Lymphoma: Role of
Intensity, Radiation, and Novel Agents
Improve Upon Standard
James L. Rubenstein, MD, PhD, University of
Therapy? California San Francisco, San Francisco, CA
Acute Lymphocytic Biology of CNS Lymphoma and the Potential
of Novel Agents
Leukemia (ALL): CHAI R:
Selina M. Luger, MD, University of Kerry J. Savage, MD, British Columbia Cancer
New Approaches in Pennsylvania, Philadelphia, PA Agency, Vancouver, Canada
Management CNS Prophylaxis for Lymphoma: Who, What,
S PEAK E R S: and When?
Herve Dombret, MD, PhD, Hpital Saint-
CHAI R:
Louis, Paris, France
Wendy Stock, MD, The University of Chicago, How and When to Decide Between
Chicago, IL Epigenetic Therapy and Chemotherapy in
Patients With AML Chronic Myeloid
S PEAK E R S:
Elli Papaemmanuil, PhD, Memorial Sloan
Leukemia (CML): Where
Monika Brueggemann, MD, University
Hospital Schleswig-Holstein, Kiel, Germany
Kettering Cancer Center, New York, NY Are We in the Current TKI
Classification and Risk Assessment in AML:
Implications of Minimal Residual Disease in Integrating Cytogenetics and Molecular
Era?
Adult ALL Profiling
Farhad Ravandi, MD, The University of Texas Alexander E. Perl, MD, University of CHAI R:
MD Anderson Cancer Center, Houston, TX Pennsylvania, Philadelphia, PA Francois-Xavier Mahon, MD, PhD, Bordeaux
Current Management of Philadelphia Role of Targeted Therapy in the Management Segalen University, Bordeaux, France
Chromosome Positive ALL and the Role of of Patients With AML
Stem Cell Transplantation S PEAK E R S:
Wendy Stock, MD, The University of Chicago, Ravi Bhatia, MD, University of Alabama at
Chicago, IL Birmingham, Birmingham, AL
How Should We Incorporate Novel Therapies Novel Approaches to Therapy in CML
Into the Management of ALL?
Francois-Xavier Mahon, MD, PhD, Bordeaux
Segalen University, Bordeaux, France
Treatment-Free Remission: Who, How, and
Why?
Javid Moslehi, MD, Vanderbilt School of
Medicine, Nashville, TN
TKI-Associated Cardiovascular Toxicity:
What to Consider
#ASH17 21
Program Guide
Education Program
S PEAK E R S:
Rachael E. Hough, BMedSci, BMBS, MD,
University College London Hospitals NHS
Foundation Trust, London, United Kingdom
Crisis Management in the Treatment of
Childhood Acute Lymphocytic Leukemia:
Putting Right What Can Go Wrong
(Emergency Complications of Disease and
Treatment)
Sharon A. Savage, MD, National Cancer
Institute, National Institutes of Health,
Bethesda, MD
Premalignant Pediatric Hematologic
Disorders: When to Treat and How
Lewis B. Silverman, MD, Dana-Farber/Boston
Childrens Cancer and Blood Disorders
Center, Boston, MA
Incorporation of Non-Chemotherapeutic
Agents in Pediatric Acute Lymphocytic
Leukemia
#ASH17 23
Program Guide
Education Program
S PEAK E R S:
J.H. Frederik Falkenburg, MD, PhD, Leiden
University Medical Center, Leiden,
Netherlands
Graft Versus Tumor Effects and Why People
Relapse
Robert J. Soiffer, MD, Dana-Farber Cancer
Institute, Boston, MA
Drugs to Prevent and Treat Relapse
Following Allogeneic Stem Cell
Transplantation
Alan Wayne, MD, Childrens Hospital Los
Angeles, Los Angeles, CA
Cells to Prevent and Treat Relapse Following
Allogeneic Stem Cell Transplantation
S PEAK E R S:
Lindsey A. George, MD, Childrens Hospital
of Philadelphia, Philadelphia, PA
Gene Therapy Comes of Age
Alfonso Iorio, MD, PhD, McMaster University,
Hamilton, Canada
Using Pharmacokinetic Data to Individualize
Therapy
Margaret V. Ragni, MD, University of
Pittsburgh, Pittsburgh, PA
Hemostatic Therapy for Patients With
Inhibitors: Beyond Bypassing Agents
Common Clinical
Questions in Cancer-
Associated Venous
Thromboembolism (VTE)
Non-Malignant Bone Marrow Failure: CHAI R:
Hematology Inherited Ingrid Pabinger, MD, Medical University of
Vienna, Vienna, Austria
CHAI R:
S PEAK E R S:
Blanche P. Alter, MD, National Cancer
Institute, National Institutes of Health, Agnes Y.Y. Lee, MD, University of British
Bone Marrow Failure: Rockville, MD Columbia, Vancouver, Canada
Acquired When Can We Stop Anticoagulation
S PEAK E R S: in Patients With Cancer-Associated
Thrombosis?
Blanche P. Alter, MD, National Cancer
CHAI R: Institute, National Institutes of Health, Marcello Di Nisio, MD, PhD, University of
Adrianna Vlachos, MD, Northwell Health, Rockville, MD Chieti-Pescara, Chieti, Italy
Manhasset, NY Inherited Bone Marrow Failure Syndromes: Incidental VTE: Is Anticoagulation Indicated?
Considerations Pre- and Post-Transplant
Ingrid Pabinger, MD, Medical University of
S PEAK E R S: Jane Churpek, MD, The University of Vienna, Vienna, Austria
Jaroslaw P. Maciejewski, MD, PhD, Taussig Chicago, Chicago, IL Direct Oral Anticoagulants: Now Also
Cancer Center, Cleveland, OH Old and New Tools in the Clinical for Prevention and Treatment of Cancer-
Clinical Implications of Somatic Mutations Diagnosis of Inherited Bone Marrow Failure Associated VTE?
in Aplastic Anemia and Myelodysplastic Syndromes
Syndromes in the Genomics Age
Rodrigo T. Calado, MD, PhD, University of
Christopher Y. Park, MD, PhD, New York Sao Paulo, Ribeiro Preto, Brazil
University School of Medicine, New York, NY Treatment of Inherited Bone Marrow Failure
Hematopoiesis, Aging, and Bone Marrow Syndromes Beyond Transplant
Failure
Adrianna Vlachos, MD, Northwell Health,
Manhasset, NY
Acquired Ribosomopathies, Red Cell Failure,
and Myelodysplastic Syndromes
#ASH17 25
Program Guide
Education Program
Christian Breymann, MD, Swiss Perinatal Seth J. Corey, MD, Virginia Commonwealth S PEAK E R S:
Institute, Zurich, Switzerland University, Richmond, VA
Jan Beyer-Westendorf, MD, University
Iron-Deficiency in Pregnancy: Clinical New Diseases, New Mechanisms, and New
Hospital Carl Gustav Carus, Dresden,
Implications and Management Therapies in Congenital Neutropenia
Germany
Douglas B. Cines, MD, University of Brian R. Curtis, PhD, BloodCenter of Superficial Vein Thrombosis
Pennsylvania, Philadelphia, PA Wisconsin, Milwaukee, WI
Marc Carrier, MD, University of Ottawa,
Thrombocytopenia in Pregnancy: Evaluation Drug-Induced Neutropenia
Ottawa, Canada
and Management Subsegmental Pulmonary Embolism
Thomas P. Loughran, MD, University of
Leslie Skeith, MD, University of Ottawa, Virginia Cancer Center, Charlottesville, VA
Marc Righini, MD, Geneva University Hospital,
Ottawa, Canada Chronic Neutropenia in Large Granular
Geneva, Switzerland
Preventing Venous Thromboembolism During Lymphocytic Leukemia and Rheumatoid
Distal Deep Vein Thrombosis
Pregnancy and Postpartum: Crossing the Arthritis
Threshold
S PEAK E R S:
Veronica H. Flood, MD, Medical College of
Wisconsin, Milwaukee, WI
Advances in the Diagnosis and Treatment of
von Willebrand Disease
Cindy Neunert, MD, Columbia University, New
York, NY
Management of Newly Diagnosed Immune
Thrombocytopenia: Can We Change
Outcomes?
Patrizia Noris, MD, University of Pavia, Pavia,
Italy
Hereditary Thrombocytopenias: A Growing
List of Disorders
#ASH17 27
Program Guide
Education Program
Therapeutic Apheresis as
an Immunomodulatory
Tool
THIS SESSION IS JOINTLY SPONSORED
WITH AABB.
CHAI R:
Jeffrey Winters, MD, Mayo Clinic, Rochester,
Rochester, MN
S PEAK E R S:
Douglas E. Gladstone, Johns Hopkins
University, Baltimore, MD
Desensitization of Human Leukocyte Antigen
Alloimmunized Recipients of Allogeneic
Transplant
Jennifer Schneiderman, Northwestern
Medicine Feinberg School of Medicine,
Chicago, IL
Extracorporeal Photopheresis for Graft
Versus Host Disease
Jeffrey Winters, MD, Mayo Clinic, Rochester,
Rochester, MN
Plasma Exchange for Thrombotic
Microangiopathies Other Than Thrombotic
Thrombocytopenic Purpura
S PEAK E R S:
#ASH17 29
Program Guide
Education Program
#ASH17 31
Program Guide
Scientific Program
Scientific Committee on
Bone Marrow Failure
Genetic Pathways That Disrupt
Hematopoietic Stem Cell Function in
Inherited Bone Marrow Failure
CHAI R:
Colin Sieff, MB, BCh, Dana-Farber/Boston
Childrens Cancer and Blood Disorders
Center, Boston, MA
S PEAK E R S:
Inderjeet Dokal, MD, Barts and Queen Marys
University London, London, United Kingdom
New Bone Marrow Failure Genes: DNAJC21
and ERCC6L2
Steven Holland, MD, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, MD
GATA2 in Bone Marrow Failure
Marc Raaijmakers, MD, PhD, Erasmus
Medical Center, Rotterdam, Netherlands
Deconstructing Niche Contributions to Bone
Marrow Failure and Leukemogenesis in
Shwachman-Diamond Syndrome
Scientific Committee on
Hematopathology and
Clinical Laboratory Scientific Committee on Scientific Committee on
Hematology Hematopoiesis Hemostasis
Hematopoietic Stem Cell Generation: Impact of the Contact Pathway on
Next-Generation Sequencing (NGS) in
Reprogramming and Expansion Disease States: Molecular
Routine Diagnostics: Are We There Yet?
Mechanisms
CHAI R:
CHAI R:
Warren S. Alexander, PhD, The Walter and CHAI R:
Maria A. Proytcheva, MD, University of
Eliza Hall Institute of Medical Research, Rodney M. Camire, PhD, Childrens Hospital
Arizona, Tucson, AZ
Parkville, Australia of Philadelphia, Philadelphia, PA
S PEAK E R S:
S PEAK E R S: S PEAK E R S:
Kojo S.J. Elenitoba-Johnson, MD, University of
Kateri A. Moore, DVM, Mount Sinai School of James H. Morrissey, PhD, University of Illinois,
Pennsylvania, Philadelphia, PA
Medicine, New York, NY Urbana, IL
NGS-Based Diagnostics in
In Vitro Hematopoietic Reprogramming and Poly-P as Modulator of Hemostasis,
Hematopathology: Strategies for
Generation of Hematopoietic Stem Cells Thrombosis, and Inflammation
Implementation in a Clinical Environment
Jonas Larsson, MD, PhD, Lund University, Patricia C. Liaw, PhD, McMaster University,
Elaine Lyon, PhD, ARUP Laboratories, Salt
Lund, Sweden Hamilton, Canada
Lake City, UT
RNAi Screens for Maintenance of Mediators of Disseminated Intravascular
Understanding the Genome: Professional
Hematopoietic Stem Cell Phenotype During Coagulation: Molecular Mechanisms
Guidelines in Clinical Genomic Testing and
Culture
Interpretation Sidney Strickland, PhD, Rockefeller University,
Kristin Hope, PhD, McMaster University, New York, NY
Torsten Haferlach, MD, Munich Leukemia
Hamilton, Canada Impact of the Coagulation System on the
Laboratory GmbH, Munich, Germany
Enforcing Post-Transcriptional Circuitries to Pathogenesis of Alzheimers Disease
Whole Exome Sequencing in Patients With
Achieve Human Hematopoietic Stem Cell
Hematologic Malignancies: Ready for Real-
Expansion
Time Precision Medicine?
#ASH17 33
Program Guide
Scientific Program
Scientific Committee on
Thrombosis and Vascular
Biology
Thrombosis: A View From the World of
Bioengineering
CHAI R:
David A. Garcia, MD, University of
Washington, Seattle, WA
S PEAK E R S:
Wilbur A. Lam, MD, PhD, Emory University/
Georgia Tech, Atlanta, GA
Thrombosis-on-a-Chip: A New Way to Model
a Complex Process
Keith B. Neeves, PhD, Colorado School of
Mines, Golden, CO
Colloidal Microwheels: A Novel Approach to
Thrombolysis?
Jeffrey Lawson, MD, PhD, Duke University,
Durham, NC
Engineered Blood Vessels
#ASH17 35
Program Guide
Scientific Program
Friday Scientific
Workshops
The Friday Scientific Workshops are interac-
tive discussions of the latest scientific devel-
opments in a particular field of hematology.
Information about specific session topics
will be available closer to the meeting at
www.hematology.org/annual-meeting and in
the annual meeting app.
Special Scientific
Symposia Alan D. DAndrea, MD, Dana-Farber Cancer
*
Acquired and Inherited Versus-Host Disease
The Center for Civil and Human
Hematologic Disease Rights is one of many recently
CHAI R:
opened attractions in Atlanta.
CHAI R: Ami S. Bhatt, MD, PhD, Stanford University,
Stanford, CA
Paul F. Bray, MD, University of Utah, Salt Lake
City, UT S PEAK E R S:
S PEAK E R S: Stanley Hazen, MD, PhD, Cleveland Clinic,
Cleveland, OH
Jinghui Zhang, PhD, St. Jude Childrens
Gut Microbiota as a Therapeutic Target for
Research Hospital, Memphis, TN
Platelet Function and Thrombosis Risks
Finding Driver Variants in Leukemia Genomic
Datasets Pavan Reddy, MD, University of Michigan,
Ann Arbor, MI
Ernest Turro, PhD, University of Cambridge,
Microbiome Metabolites Regulate Graft-
Cambridge, United Kingdom
Versus-Host Disease
Statistical and Genomic Approaches in Rare
Disease Research
#ASH17 37
Program Guide
Scientific Program
Sunday, December 10
11:15 a.m. 12:15 p.m.
Monday, December 11
12:15 p.m. 1:15 p.m.
#ASH17 39
Continuing Education
Educational Objectives
Upon completion of this educational activity,
participants should be able to:
Employ the knowledge gained regarding
the diagnosis and treatment of non-malig-
nant and malignant hematologic disorders
to improve patient care
D
iscuss state-of-the-art research in hematology
Analyze the potential contribution of novel,
not-yet-approved modalities of therapy to
current evidence-based management of
hematologic disorders
How to Claim CME Conflict-of-Interest Policy
Credit/ABIM MOC Points for the ASH Annual
CME or Request a Certificate Meeting
of Attendance
The American Society of Hematology (ASH) ASH is committed to providing quality, objec-
is accredited by the Accreditation Council for The deadline to claim CME credits and tive, balanced, and scientifically rigorous
Continuing Medical Education (ACCME) to ABIM MOC points or to request a continuing medical education activities that
provide continuing medical education (CME) Certificate of Attendance is April 13, 2018. are free from commercial and non-commer-
for physicians. cial bias. In accordance with the rules of
ASH designates this live activity for a If you plan to claim CME credit or ABIM the ACCME, all meeting session chairs,
maximum of 36.5 AMA PRA Category 1 MOC points for your participation at the meet- speakers, and moderators are required to
Credits. Physicians should claim only the ing, please check the appropriate box during disclose any conflicts they may have in writ-
credit commensurate with the extent of their the registration process. In order to claim ing prior to the meeting. All poster present-
participation in the activity. CME credit and ABIM MOC points or to ers are required to disclose any conflicts
request a Certificate of Attendance, you must they may have in writing prior to the meeting
ASH is accredited to provide AMA PRA complete the online program evaluation. The and display their disclosures on their poster
Category 1 Credits to physicians only. The evaluation can be accessed once the meeting boards. If bias, actual or perceived, occurs
American Medical Association (AMA) defines is underway by clicking the CME Certificate during a presentation, session attendees are
physicians as those individuals who have link at www.hematology.org/annual-meeting. encouraged to address such bias during the
obtained an MD, DO, or equivalent medical The evaluation will be available on the ASH question-and-answer period following the
degree from another country. website through April 13, 2018. presentation.
Physicians not licensed in the United States A processing fee of $25 will be charged for Annual meeting contributors are asked to
who participate in this CME activity are also CME credit/ABIM MOC points. disclose any relationships of the following
eligible for AMA PRA Category 1 Credits. types: employment, consultancy, equity
ownership, research funding, honoraria,
Non-physicians may request a certificate of
patents and royalties, speakers bureau,
attendance for their participation.
membership on an entitys board of direc-
CME and ABIM MOC Accreditation
tors or advisory committee, and any other
of Hematology 2017
financial relationship.
ABIM MOC ASH will be offering CME credit and Any questions about this policy or concerns
ABIM MOC points to physicians upon regarding disclosures should be directed
completion of multiple-choice questions to the ASH Meeting and CME Information
Successful completion of this CME activity,
based on the manuscripts in Hematology Desk in ASH Central located in Building B,
which includes participation in the evaluation
2017, the ASH Education Program. Level 1, Hall B1 or by emailing
component, enables the participant to earn
cme@hematology.org.
American Board of Internal Medicine (ABIM) ASH designates this enduring material
Maintenance of Certification (MOC) points. for a maximum of 40 AMA PRA Category
Attendees will earn ABIM MOC points 1 Credits. Physicians should claim only
equivalent to the number of CME credits the credit commensurate with the extent
claimed for the activity. of their participation in the activity.
If you are an ABIM diplomate, you will be Physicians may earn up to 40 credits
asked to submit a reflective statement on how by taking two 20-credit exams one
you intend to change your practice based on on malignant hematology and the other
the knowledge you gained from participation in on non-malignant hematology. More
the meeting. Upon review and approval of your information will be available this fall at
statement, your points will be submitted to the www.ashacademy.org.
ABIM by ASH.
Exhibit Hall
Visit the state-of-the-art exhibit hall (Building B, Level 1,
Halls B2-B4) to see the latest technology and research, and
learn about a wide range of products and services offered
by more than 250 exhibitors, including pharmaceuti-
cal companies, medical suppliers, publishers, nonprofit
organizations, and clinical diagnostic and research-based
companies.
Hours
Saturday, December 9 11:00 a.m. 5:00 p.m.
Sunday, December 10 10:00 a.m. 5:00 p.m.
Monday, December 11 10:00 a.m. 2:00 p.m.
Hours
Sunday, December 10 11:00 a.m. 12:30 p.m.
Monday, December 11 12:00 noon 1:30 p.m.
Hours
Saturday, December 9 11:30 a.m. 12:30 p.m.
Sunday, December 10 11:30 a.m. 12:30 p.m.
Monday, December 11 12:15 p.m. 1:15 p.m.
ASH Booth
Stop by the ASH Booth (#1933) to learn about the Societys resourc-
es and opportunities for hematologists at all career levels. ASH staff
will be available at the booth to answer questions about ASH meet-
ings, programs, resources, and initiatives and to assist with member-
ship applications and renewals. While you are at the booth, be sure to
grab the most recent issues of ASH publications, including Blood, The
Hematologist, and ASH Clinical News. Remember to ask about the
product discounts available exclusively at the annual meeting.
#ASH17 41
Social Activities
Start your day in a fun, healthy, and philanthropic way by participating in the fifth annual ASH
Foundation Run/Walk before attending the Sunday sessions. Participants may run or walk
through the designated event course in Atlanta, choosing either a 3K or 5K route.
Proceeds from all individual and group registration fees as well as additional individual dona-
tions will benefit the ASH Sickle Cell Disease Initiative
Registration Fees Fund. ASH and the ASH Foundation may opt to desig-
nate a portion or all of corporate sponsorship revenues
Networking Events
Individuals $50 associated with the Run/Walk to help support the cost of
Join your colleagues for social and network-
administering the event.
Trainees $35 ing events throughout the annual meeting.
Learn more and register at www.hematology.org/runwalk.
Welcome Reception
Saturday, December 9
5:30 p.m. 7:30 p.m.
This event will be held in the poster hall
(Building A, Level 1, Hall A2).
Promoting Minorities in
Hematology Presentations
and Reception
ASH Foundation Donor Lounge To learn more, see page 16.
All individuals who have donated $250 or more throughout the 2017 calendar year
are invited to visit the ASH Foundation Donor Lounge on the International Boulevard
Concourse between Buildings A and B. Trainee Welcome
The ASH Foundation is dedicated to advancing hematology through private chari- Reception
table support for research, career development, quality care, and education. Your
Open only to attendees with a blue trainee
donation helps enhance and expand existing ASH programs and pursue new, vision-
badge. To learn more, see page 18.
ary initiatives allowing ASH to do more for hematology worldwide. One hundred
percent of charitable gifts to the ASH Foundation directly benefit programs spon-
sored by ASH and are tax deductible as allowable by law.
Find all essential attendee services together in one convenient location. ASH Central offers a place for
attendees to relax, collaborate, view sessions remotely, purchase ASH products, and more. ASH Central will be
located in Building B, Level 1, Hall B1.
To find out which sessions will be broadcast Hematology 2017, the ASH Education
in the remote session viewing area, please Program
check the annual meeting mobile app closer ASH annual meeting webcasts
to the meeting.
Attendees will also be able to apply for or
renew their membership at the ASH Store.
#ASH17 43
ASH Central Resources for Parents
Child Care
For safety reasons, children under the age of 12 are not permitted in the exhibit hall
or poster halls. Additionally, ASH prohibits children and infants in sessions, as they
may distract the speakers and other attendees.
Collaboration Rooms ASH has made arrangements with KiddieCorp to provide subsidized child-
care services on site from Friday, December 8, through Tuesday, December 12.
Small conference rooms for 10-20 people KiddieCorp staff members are certified child-care specialists. The cost to parents
will be available for attendees to collabo- will be $5 per hour, per child, with a two-hour minimum required per child, per day.
rate in a more private space. Rooms will be Snacks, light meals, and beverages will be provided each day.
pre-set with a conference table and chairs;
and each attendee will be limited to one To register and for additional program information, please contact KiddieCorps
45-minute reservation per day. Program Manager, Lesley Medina, at 800-942-9947 ext. 201, or visit
www.kiddiecorp.com.
Interested in reserving a room?
Reservation requests may be submitted Space is limited, so please register your child by November 3 to ensure participation.
beginning September 27 at
www.hematology.org/annual-meeting or
Child Care Hours
through the annual meeting mobile app.
Reservations may also be made on site in Friday, December 8 6:30 a.m. 7:30 p.m.
ASH Central. Please note that space is
limited and available on a first-come, first- Saturday, December 9 6:30 a.m. 7:30 p.m.
served basis. Back-to-back reservations are
prohibited. Sunday, December 10 6:30 a.m. 8:00 p.m.
Monday, December 11 6:30 a.m. 8:00 p.m.
Tuesday, December 12 6:30 a.m. 1:00 p.m.
Lactation Room
Nursing mothers will have a calm restful environment for their pumping sessions
during the ASH annual meeting. Each nursing mothers lounge will provide a private,
comfortable area equipped with lockable doors, furniture, and power outlets.
Lounges will be available in safe, accessible areas throughout the convention center.
For exact locations, please refer to the annual meeting app or to the printed ASH
Selfie Zone Campus Map on site.
Trainee Lounge
Open only to those with a blue trainee
badge, this space is designed for trainees to
*
gather, regroup, and recharge. For Trainee
Lounge hours, see page 20. The Georgia Aquarium is the largest aquarium in the
Western Hemisphere. Its notable specimens include
whale sharks, beluga whales, and bottlenose dolphins.
#ASH17 45
Registration and Hotel Information
Contact the ASH Registration and Housing Center. Monday, December 11 7:00 a.m. 5:00 p.m.
Assistance is available Monday through Friday from 8:30 Tuesday, December 12 7:00 a.m. 1:30 p.m.
a.m. to 5:00 p.m. Eastern Time.
Phone: 888-273-5704
(International callers dial 001-703-449-6418)
Meeting badges will be mailed in mid-November to all
Email (Registration): ashregistration@spargoinc.com those registered by November 1.
Email (Housing): ashhousing@spargoinc.com
Headquarters and
Member Hotels
The Omni Atlanta at CNN Center is the official headquarters hotel for
the 2017 ASH Annual Meeting and is designated for ASH members
only. In addition, the following hotels are available to Society members:
AC Atlanta Hotel Downtown
Aloft AtlantaHotel Downtown
Courtyard Atlanta Downtown
DoubleTree by Hilton Atlanta Downtown
The Ellis Hotel
Embassy Suites Centennial Park
Glenn Hotel, an Autograph Collection
Hampton Inn & Suites AtlantaDowntown
Hilton Garden Inn Atlanta Downtown
Holiday Inn Express & SuitesAtlanta Downtown
HOME2 Suites by Hilton Atlanta Downtown
Hyatt Regency Atlanta
Inn at the Peachtrees
Marriott Marquis Atlanta
The Ritz-Carlton Atlanta
Westin Peachtree Plaza
#ASH17 47
Upcoming ASH Meetings
Asia-Pacific
Bali, Indonesia (March 9-10)
Latin America
Rio de Janeiro, Brazil (April 27-28)
Rio de Janeiro, Brazil
O
Kenneth C. Anderson, MD, President
Scott A. Armstrong, MD, PhD Joseph R. Mikhael, MD
n behalf of the American Society of Hematology 2017 Scientific Program Co-Chair Chair, Committee on Communications Alexis Thompson, MD, MPH, President-Elect
(ASH), I am pleased and honored to invite you to the Belinda R. Avalos, MD Charles Mullighan, MBBS (Hons), MD Roy L. Silverstein, MD, Vice President
Chair, Committee on Promoting Diversity Chair, Committee on Scientific Affairs Robert A. Brodsky, MD, Secretary
59th ASH Annual Meeting and Exposition, the premier
Nancy Berliner, MD Robert Negrin, MD Susan B. Shurin, MD, Treasurer
event in malignant and non-malignant hematology. This Deputy Editor, Blood Editor-in-Chief, Blood Advances COUNCILLORS
years meeting will take place in the vibrant city of Atlanta, Robert A. Brodsky, MD Laurie Sehn, MD Steven L. Allen, MD
Georgia, and will continue to provide an exceptional Secretary and Abstract Review Coordinator 2017 Education Program Co-Chair
John C. Byrd, MD
Theresa L. Coetzer, PhD Mikkael A. Sekeres, MD
educational experience and welcoming space for trainees, Chair, International Members Committee Editor-in-Chief, ASH Clinical News;
Mary C. Dinauer, MD, PhD
Cynthia E. Dunbar, MD
physicians, scientists, educators, and industry professionals John Crispino, PhD
2018 Education Program Co-Chair
Terry Gernsheimer, MD
in hematology from around the globe. 2018 Scientific Program Co-Chair Roy L. Silverstein, MD
Michelle M. Le Beau, PhD
Vice President
Mark A. Crowther, MD
Martin S. Tallman, MD
Chair, Committee on Quality; Martha Sola-Visner, MD
We have an exciting program planned, which includes 2018 Education Program Co-Chair 2018 Scientific Program Co-Chair Jane N. Winter, MD
the highest-caliber science and invaluable information on Adam Cuker, MD Martin S. Tallman, MD
2017 Education Program Co-Chair Executive Editor, Hematology 2017
the most important areas of clinical progress. In the era of
Jason Gotlib, MD Alexis Thompson, MD, MPH
precision medicine, I am particularly excited to highlight Editor-in-Chief, The Hematologist President-Elect
Kenneth C. Anderson, MD the high-impact and cross-cutting areas of genomics and Michael L. Linenberger, MD Andrew S. Weyrich, PhD
President Chair, Committee on Educational Affairs 2017 Scientific Program Co-Chair
immunology, which are making it possible to take these
revolutionary treatments from the bench to the bedside,
directly benefiting the patients we serve. These topics and
others will be explored throughout the meeting in a forum
that fosters scientific exchange and collaboration.
#ASH17 49
59th ASH
Annual Meeting
and Exposition
December 9-12 Atlanta, Georgia